PT-141 (Research Grade)

PT-141 (Bremelanotide) is an investigational synthetic cyclic peptide and melanocortin receptor agonist studied in laboratory research involving melanocortin receptor signaling, including MC3R- and MC4R-associated pathways. Research settings commonly examine its interaction with neuroendocrine signaling, receptor activation, and related biochemical response pathways.

This product is supplied in lyophilized powder form to support product stability, storage longevity, and controlled laboratory handling.

Key Features:

• Intended strictly for laboratory research use
• Synthetic cyclic peptide also known as Bremelanotide or PT-141
• Commonly studied in laboratory settings involving melanocortin receptor signaling and MC3R/MC4R-associated pathways
• Lyophilized formulation designed for enhanced stability and storage longevity

Specifications:

• Available Quantities: 10mg per vial
• Format: Lyophilized powder
• Storage Conditions: Store in a cool, dry environment away from direct light
• Handling: Use standard laboratory handling procedures

Research Use Notice:

This product is intended solely for laboratory and analytical research purposes.
Not intended for human or veterinary consumption, treatment, diagnostic, or medical applications.